Comstock (CHCI) Files Form 144 to Sell 10,000 Common Shares

Rhea-AI Filing Summary

Comstock Holding Companies, Inc. (CHCI) submitted a Form 144 notice disclosing a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney LLC, Executive Financial Services on the NASDAQ with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $136,900 and reports 9,851,162 shares outstanding for the issuer. The shares were acquired as restricted stock awards on 12/04/2004 and the quantity to be sold matches the amount originally awarded (10,000).

The Form indicates no securities sold in the past three months by the reporting person and includes the standard representation that the signer does not possess undisclosed material adverse information. No plan adoption date for a Rule 10b5-1 trading plan is provided in the filing.

Positive

• Transparency provided: The filer disclosed broker, transaction size, acquisition history, and aggregate market value.
• No recent sales: The filing states "Nothing to Report" for securities sold during the past three months.

Negative

• Proposed insider sale: The filer intends to sell 10,000 common shares valued at $136,900, which may be viewed negatively by some investors.
• No 10b5-1 plan date provided: The form does not specify a trading-plan adoption date, so the sale is reported as a proposed transaction rather than clearly under a pre-established plan.

Insights

Securities Analyst

TL;DR: Routine Form 144 notifying a proposed insider sale of 10,000 CHCI shares valued at $136,900; no recent sales reported.

The filing is a standard regulatory disclosure that notifies the market the holder intends to sell 10,000 common shares on or about 08/11/2025 via Morgan Stanley Smith Barney on NASDAQ. The shares were acquired as restricted stock awards in 2004 and the filing explicitly states there were no sales in the prior three months. This notice provides transaction transparency but contains no operational or earnings data to change a valuation model.

Corporate Governance Expert

TL;DR: Formal compliance disclosure with the usual signer representation regarding material nonpublic information; no Rule 10b5-1 plan date stated.

The Form includes the required representation that the reporting person is not aware of undisclosed material adverse information. The filing does not list a Rule 10b5-1 plan adoption date or other instructions, which means the sale appears reported as a proposed transaction rather than under an explicitly dated trading plan. The disclosure of broker details and acquisition history (restricted awards in 2004) supports traceability of the holding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	136900.00	9851162	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/04/2004	Restricted Stock Awards	Issuer			10000	12/04/2004	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CHCI shares are proposed to be sold in the Form 144?

The filing proposes the sale of 10,000 common shares.

What is the aggregate market value of the shares to be sold?

The aggregate market value listed is $136,900.

When is the approximate date of sale for the CHCI shares?

The approximate date of sale shown in the filing is 08/11/2025.

Who is the broker handling the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

When were the shares being sold originally acquired?

The shares were acquired as restricted stock awards on 12/04/2004.

Has the reporting person sold any CHCI securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.